The FDA convened a high‑stakes hearing on accelerating psychedelic therapy development, hearing from 80 witnesses.
Officials pledged rigorous scientific standards while industry leaders urged streamlined pathways.
FDA hearing seeks faster psychedelic therapy approvals
The FDA convened a high‑stakes hearing on accelerating psychedelic therapy development, hearing from 80 witnesses.
Officials pledged rigorous scientific standards while industry leaders urged streamlined pathways.
Public opinion shifts as marijuana seen as less dangerous
A recent poll shows only one‑third of Americans consider marijuana dangerous and fewer than half believe the gateway theory.
This changing view fuels growing political support for legalization.
Union urges voters to reject cannabis rollback
SEIU Massachusetts State Council warned that the November ballot initiative to undo legalization threatens progress.
“The fight to protect legal marijuana is about protecting progress,” the union said.
Minnesota hits $250 million in recreational sales in one year
The Minnesota Office of Cannabis Management reported retailers have sold over $250 million in legal marijuana products since the market launched a year ago.
State officials credit robust sales to well‑regulated dispensaries and effective enforcement.
DEA moves into cannabis regulation role
Analysts say the DEA is shifting from enforcement to day‑to‑day industry regulation as the Trump administration pursues rescheduling.
An op‑ed highlighted this transition and its market implications.
Congress advances 12‑year exclusivity for botanical drugs
Reps. Lauren Boebert (R‑CO) and Derrick Van Orden (R‑WI) filed legislation offering a 12‑year market exclusivity period for newly approved plant‑based medicines, including cannabis and psychedelics.
Supporters argue the bill will accelerate research and commercialization.
State actions across the country
Delaware’s governor will rename its enforcement division to include marijuana oversight on Wednesday.
Texas lieutenant governor candidate Vikki Goodwin publicly backs cannabis legalization.
California regulators recalled products for child‑appealing packaging and pesticide violations.
Pennsylvania health secretary limited solvent‑based extraction to topical use to curb microbial contamination.
Nebraska regulators postponed finalizing updated medical cannabis rules until next year.
Colorado published guidance on residual solvent testing for cannabis products.
Vermont released eligibility criteria for property tax credits to cannabis business owners.
Washington, D.C. warned of a phishing scam targeting medical cannabis and alcohol businesses.
Oregon convened hearings on proposed psilocybin service rule changes.
Massachusetts will host a cannabis social‑equity application clinic on Wednesday.
Local and international updates
Harris County, Texas, will hold a record‑expungement clinic for marijuana offenses on September 26.
A Maltese legislator calls for an independent review of the country’s cannabis laws.
Science, health and advocacy
Research shows cold‑pressed industrial hemp seed oil accelerates wound healing.
A review found psilocybin can reduce psychosomatic symptoms for weeks to years after use.
The Parabola Center for Law and Policy released a report recommending tools for equitable global cannabis market design.
Business moves
Curaleaf urged Aurora Cannabis to accept its acquisition offer.
Innovative Industrial Properties declared a $1.90 per share quarterly dividend.
Woody Harrelson joked about smoking marijuana with Matthew McConaughey’s mother.
Stay informed – subscribe to Marijuana Moment’s daily dispatch.
Support our reporting by pledging $25 per month on Patreon.
